Disease Severity, Mortality Risk, and Muscle Function in Intensive Care Unit Patients
Relationship of Disease Severity and Mortality Risk With Respiratory Muscle Strength, Muscle Biomechanical Properties, and Muscle Architecture in Intensive Care Unit Patients
1 other identifier
observational
45
1 country
1
Brief Summary
Intensive Care Units are specialized, technologically advanced hospital units that provide continuous monitoring and care from multiple healthcare disciplines for patients who are critically ill and face a high risk of death or serious health problems. Prolonged periods of immobility, which are common during treatment in these units, can cause serious complications such as muscle weakness, decline in physical function, and a lower quality of life. There are scoring systems designed to predict the severity of a patient's illness and their likely outcomes, such as the scoring system called the Acute Physiology and Chronic Health Evaluation version two. However, these scoring systems are not yet widely used as a regular part of patient care. Although weakness and wasting of muscles away from the center of the body are known to affect the recovery process of patients who survive intensive care treatment, the connection between how severe the illness is and the strength of the muscles used for breathing, the structure of peripheral muscles, and their biomechanical characteristics is still not fully understood. This study aims to explore these relationships to help improve physiotherapy and rehabilitation treatments for patients in intensive care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedAugust 15, 2025
August 1, 2025
1 month
August 9, 2025
August 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Course of Disease in Intensive Care Patients, Mortality risk:
The patient's mortality rate will be assessed using the Acute Physiology and Chronic Health Evaluation II score. The Acute Physiology and Chronic Health Evaluation II score is commonly used for patients treated in the intensive care unit. It is based on an initial score comprising 12 components and is evaluated on a scale from 0 to 71 points. The assessment consists of three sections: physiological scores ranging from 0-60 points, age scores ranging from 0-6 points, and comorbidity scores ranging from 0-5 points. A higher total Acute Physiology and Chronic Health Evaluation II score indicates greater severity of the patient's condition (15).
4 weeks
Assessment of Peripheral Muscle Architecture:
Quadriceps femoris muscle thickness will be measured as the distance between the upper border of the femur and the lower border of the subcutaneous tissue. Measurements will be taken 15 cm proximal to the superior border of the patella using a tape measure (19). After each patient, the ultrasound probe will be disinfected by wiping with 70% isopropyl alcohol.
4 weeks
Secondary Outcomes (6)
Muscle Tone:
4 weeks
Measurement of Respiratory Muscle Strength:
4 weeks
Elasticity:
4 weeks
Dynamic Stiffness
4 weeks
Creep:
4 weeks
- +1 more secondary outcomes
Study Arms (1)
Critical care patient
Critical care patients are going to be meaasured
Eligibility Criteria
Patients admitted to the intensive care unit who are not dependent on mechanical ventilation and meet the inclusion and exclusion criteria will be included in the study.
You may qualify if:
- Not dependent on mechanical ventilation,
- Patient or legal representative provides consent to participate,
- Aged 18 years or older,
- Monitored in the ICU for at least 48 hours.
You may not qualify if:
- Unable to obtain ethical consent,
- Presence of neuromuscular disease affecting muscle tone,
- Patients unable to cooperate during measurement due to impaired consciousness, communication disorder, or other medical reasons,
- Presence of infection, open wound, or any lesion impairing skin integrity at the anatomical measurement site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istinye University Bahçeşehir Liv University Hospital
Istanbul, Esenyurt, 34000, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant (PhD student)
Study Record Dates
First Submitted
August 9, 2025
First Posted
August 15, 2025
Study Start
August 15, 2025
Primary Completion
September 15, 2025
Study Completion
October 30, 2025
Last Updated
August 15, 2025
Record last verified: 2025-08